Immuneering refers to the specialized application of advanced computational biology, bioinformatics, and machine learning platforms to analyze complex biological datasets, map cellular signaling networks, and discover novel therapeutic drug candidates. Companies utilizing this approach integrate big data analytics with traditional wet-lab experiments to accelerate the identification of precision medicines targeting treatment-resistant diseases, particularly in oncology.